Pharmacokinetic behavior of IB1001, an investigational recombinant factor IX, in patients with hemophilia B: Repeat pharmacokinetic study and subgroup analysis

U. Martinowitz, Department of Internal Medicine, Israel National Hemophilia Center, Tel Hashomer 52621, Israel

Blood. 2011;118((21):): Abstract No. 2267.